Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8243653 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 12 Pages |
Abstract
Conclusion: Radiation proctopathy should be an important consideration for the clinician in the treatment of prostate cancer especially with dose escalation. With further study of possible risk factors, the advent of a standardized grading scale, and more randomized trials to evaluate treatments, patients and physicians will be better armed to make appropriate management decisions.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Amit K. M.D., Wei-Yuan M.D., John E. Ph.D., Walter H. Ph.D., E. Brian M.D., Bin S. M.D.,